NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) Stock Price

NAMSStock

$27.34+7.40%52W

Market Cap$3.20B

P/E—

PEG Ratio—

Div yield—

Beta0.09

NAMS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-36.16%

Price vs S&P 500 (4W)-7.09%

VGM Score19.37

Book Value / Share (Quarterly)$5.37

P/TBV (Annual)5.82x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-38.66%

Cash Flow / Share (Quarterly)$0.04

Price vs S&P 500 (YTD)-35.42%

Net Profit Margin (TTM)-3644.21%

EPS (TTM)$-2.15

10-Day Avg Trading Volume1.14M

EPS Excl Extra (TTM)$-2.15

EPS (Annual)$-1.72

ROI (Annual)-29.82%

Cash / Share (Quarterly)$5.39

Revenue Growth QoQ (YoY)-80.67%

ROA (Last FY)-26.49%

Revenue Growth TTM (YoY)-88.87%

EBITD / Share (TTM)$-2.02

ROE (5Y Avg)-39.32%

Operating Margin (TTM)-3432.20%

Cash Flow / Share (Annual)$-1.29

P/B Ratio5.28x

P/B Ratio (Quarterly)6.27x

Net Income / Employee (Annual)$-2,038,200

EV / Revenue (TTM)408.28x

Net Interest Coverage (TTM)-6.44x

ROA (TTM)-34.68%

EPS Incl Extra (Annual)$-1.72

Current Ratio (Annual)7.88x

Quick Ratio (Quarterly)8.78x

3-Month Avg Trading Volume1.22M

52-Week Price Return7.40%

Revenue / Employee (TTM)$71,200

Tangible BV / Share (Quarterly)$5.36

P/S Ratio (Annual)148.05x

Asset Turnover (Annual)0.03x

52-Week High$42.20

EPS Excl Extra (Annual)$-1.72

CapEx CAGR (5Y)89.75%

26-Week Price Return-24.92%

Quick Ratio (Annual)7.70x

13-Week Price Return-24.87%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)9.03x

Enterprise Value$2.91B

Asset Turnover (TTM)0.01x

Revenue / Employee (Annual)$225,000

Pretax Margin (Annual)-905.74%

Cash / Share (Annual)$5.56

3-Month Return Std Dev47.88%

Net Income / Employee (TTM)$-2,595,000

ROE (Last FY)-29.82%

EPS Basic Excl Extra (Annual)$-1.72

P/FCF (TTM)28.38x

EV / Free Cash Flow (TTM)675.03x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-2.15

ROI (TTM)-38.33%

P/S Ratio (TTM)467.84x

Revenue / Share (Annual)$0.19

Tangible BV / Share (Annual)$5.97

Price vs S&P 500 (52W)-10.91%

Year-to-Date Return-23.46%

5-Day Price Return-1.47%

EPS Normalized (Annual)$-1.72

ROA (5Y Avg)-33.58%

Net Profit Margin (Annual)-905.74%

Month-to-Date Return-3.38%

Cash Flow / Share (TTM)$-0.26

EBITD / Share (Annual)$-1.90

Operating Margin (Annual)-1002.90%

P/CF (TTM)771.00x

ROI (5Y Avg)-39.27%

EPS Basic Excl Extra (TTM)$-2.15

P/TBV (Quarterly)6.28x

P/B Ratio (Annual)5.82x

Pretax Margin (TTM)-3644.21%

Book Value / Share (Annual)$5.97

Price vs S&P 500 (13W)-27.67%

Beta0.09x

P/FCF (Annual)418.53x

Revenue / Share (TTM)$0.06

ROE (TTM)-38.33%

52-Week Low$23.05

vGradeF

gGradeF

mGradeD

vgmGradeF

NAMS Earnings Surprise History

Q2 25-0.13est. -0.43

Q3 25-0.53est. -0.34

Q4 25-0.53est. -0.37

Q1 26-0.34est. -0.41

Q2 26-0.45est. -0.43

NAMS Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.32

4.30

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
NAMSNewAmsterdam Pharma Company N.V. Ordinary Shares	F	F	D	$27.34
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About NewAmsterdam Pharma Company N.V. Ordinary Shares

NewAmsterdam Pharma is a biopharmaceutical company developing therapies for cardio-metabolic diseases, focusing on patients where current treatments are inadequate or poorly tolerated. The company's lead candidate, obicetrapib, is an oral CETP inhibitor designed to lower LDL cholesterol and address limitations of existing LDL-lowering treatments.